Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome

As palmitoylethanolamide modifies overactive mast cells and reduce inflammation, this compound is a interesting treatment modality, see also http://www.dovepress.com/evolution-in-pharmacologic-thinking-around-the-natural-analgesic-palmi-peer-reviewed-article-JPR

Mastopedia Research Feed

http://www.ncbi.nlm.nih.gov/pubmed/23667756

J Neurogastroenterol Motil. 2013 Apr;19(2):244-50. doi: 10.5056/jnm.2013.19.2.244. Epub 2013 Apr 16.

Lee H, Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Chae SW, Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea

Abstract

BACKGROUND AIMS: Although mucosal mast cell tryptase is known to significantly increase intestinal permeability, the relationship between mucosal mast cells and intestinal permeability remains unclear. The objective of this study was to evaluate the correlation among intestinal permeability, tryptase activity and mucosal mast cell count.

METHODS:

Rectal biopsies from 16 patients with diarrhea-predominant irritable bowel syndrome (IBS-D) and 7 normal subjects were assessed for tryptase activity and macromolecular permeability using horseradish peroxidase in Ussing chambers. In addition, mucosal mast cell levels were immunohistochemically quantified via image analysis.

RESULTS:

Rectal biopsy of tissues from IBS-D patients…

View original post 126 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: